Puma Biotechnology Lands $55,000,000 New Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c1709554-efa9-4532-bc0a-0a9c13a7b37d&Preview=1 -
Date
10/5/2011 -
Company Name
Puma Biotechnology -
Mailing Address
10940 Wilshire Blvd Los Angeles, CA 90024 -
Company Description
Puma Biotechnology, Inc. is a development-stage biopharmaceutical company dedicated to in-licensing and developing novel therapeutics for the treatment of cancer. -
Website
http://www.pumabiotechnology.com -
Transaction Type
Venture Equity -
Transaction Amount
$55,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds from the private placement will be used primarily to fund the continued clinical development of neratinib. -
M&A Terms
-
Venture Investor
Adage Capital Management -
Venture Investor
Hambrecht & Quist Capital Management -
Venture Investor
OrbiMed
